David C. Park, MD

David C. Park, MD

David C. Park, MD
phone icon
checkmark iconAccepting new patients
"

Address

622 West 168th Street
New York, NY 10032
US

insurance iconinsurance icon
Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • Aetna
  • AgeWell
  • Capital District Physician Health Plan
  • Cigna
  • Emblem/GHI
  • Emblem/Hip
  • Empire Blue Cross Blue Shield
  • Local 1199
  • Magnacare
  • Multiplan
  • MVP Health Care
  • Oxford Health Plans
  • UnitedHealthcare

about iconabout icon
About David C. Park, MD

I am a board-certified pathologist with subspecialty expertise in hematopathology who joined the Division of Hematopathology in the Department of Pathology and Cell Biology at Columbia University Medical Center as an assistant professor in July 2017. It is an honor and a privilege to work alongside colleagues at CUMC within the Division of Hematopathology, and the Division of Hematology/Oncology in the Department of Medicine to provide an accurate and timely diagnosis on every sample so that all patients receive the best treatment possible. My expertise is in diagnosing common and uncommon/rare hematologic conditions, which can be either benign or malignant, using morphology, immunohistoc...
I am a board-certified pathologist with subspecialty expertise in hematopathology who joined the Division of Hematopathology in the Department of Pathology and Cell Biology at Columbia University Medical Center as an assistant professor in July 2017. It is an honor and a privilege to work alongside colleagues at CUMC within the Division of Hematopathology, and the Division of Hematology/Oncology in the Department of Medicine to provide an accurate and timely diagnosis on every sample so that all patients receive the best treatment possible. My expertise is in diagnosing common and uncommon/rare hematologic conditions, which can be either benign or malignant, using morphology, immunohistochemistry/in situ hybridization, flow cytometry, cytogenetics and molecular genetics based studies at CUMC. Malignant (cancerous) neoplasms are usually classified as either myeloid or lymphoid in nature such as acute myeloid leukemia or diffuse large B-cell lymphoma, respectively. My research interests are focused primarily on aggressive myeloid neoplasms, particularly those arising from bipotent megakaryocyte-erythroid progenitors (MEPs). As MEP malignancies are particularly difficult to diagnose and associated with very poor survival due to lack of effective therapies, my research goals are to identify useful and novel diagnostic, prognostic and therapeutic biomarkers of disease. Prior to joining CUMC, I was a faculty member of the Division of Hematopathology in the Department of Pathology at Memorial Sloan Kettering Cancer Center for 5 years. I completed residency and fellowship training at Brigham and Women's Hospital, a major teaching hospital of Harvard Medical School, in Boston, Massachusetts, after graduating from the University of Illinois College of Medicine. Email: dcp2137@cumc.columbia.edu

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Expertise

  • Acute Lymphoblastic Leukemia
  • Acute Myelogenous Leukemia/AML
  • Chronic Myelogenous Leukemia
  • CMML (Chronic Myelomonocytic Leukemia)
  • Essential Thrombocythemia
  • Hodgkin's Lymphoma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myelofibrosis
  • Non-Hodgkin's Lymphoma
  • Polycythemia Vera

Board Certifications

  • Anatomic Pathology and Clinical Pathology

GET AN EXPERT SECOND OPINION

Learn More